Cargando…
Multiple dosing strategies with acetyl L-carnitine (ALCAR) fail to alter age-related hearing loss in the Fischer 344/NHsd rat
BACKGROUND: The Fischer 344/NHsd rat undergoes age-related, progressive, high-frequency hearing loss beginning at age 12 months. The loss has been linked to defects/death in the outer hair cells related to oxidative stress originating in the mitochondria. Acetyl L-carnitine (ALCAR) is known to enhan...
Autores principales: | Bielefeld, Eric C, Coling, Donald, Chen, Guang-Di, Henderson, Donald |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491592/ https://www.ncbi.nlm.nih.gov/pubmed/18620587 http://dx.doi.org/10.1186/1477-5751-7-4 |
Ejemplares similares
-
Deciphering the potential efficacy of acetyl-L-carnitine (ALCAR) in maintaining connexin-mediated lenticular homeostasis
por: Muralidharan, Arumugam Ramachandran, et al.
Publicado: (2012) -
Acetyl-L-carnitine (ALCAR) to enhance nerve regeneration in carpal tunnel syndrome: study protocol for a randomized, placebo-controlled trial
por: Curran, Matthew W. T., et al.
Publicado: (2016) -
Anti-Hyperalgesic Efficacy of Acetyl L-Carnitine (ALCAR) Against Visceral Pain Induced by Colitis: Involvement of Glia in the Enteric and Central Nervous System
por: Lucarini, Elena, et al.
Publicado: (2023) -
Diet for Fischer-344 rats in long-term studies.
por: Rao, G N
Publicado: (1994) -
Acetyl-l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
por: Callander, Natalie, et al.
Publicado: (2014)